Recognizing encephalopathy in immune checkpoint inhibitor therapy: A single‐center experience

Abstract Background In this pilot study, we examined the characteristics of patients with and without central nervous system (CNS) malignancies who developed immune checkpoint inhibitor (ICI)‐induced encephalopathy. Methods We identified adult patients treated with ICIs between 1 January 2013 and 9...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Danmeng Wei, Daniel J. Zhou, Proleta Datta, Olga Taraschenko
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2021-05-01
coleção:	Cancer Medicine
Assuntos:	altered mental status encephalopathy immune checkpoint blockade immunotherapy for cancer neurotoxicity
Acesso em linha:	https://doi.org/10.1002/cam4.3818
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!